Indicators for the 22 conditions were developed, modified or updated from CareTrack: assessing the appropriateness of health care delivery in Australia
The Medical Journal of Australia ISSN: 0025-729X 16 July 2012 197 2 100-105 ©The Medical Journal of Australia 2012 www.mja.com.au Research ow appropriate is the health care delivered to Australians? A seminal study in the United States showed that American adults received "recommended care" only 55% of the time in the years 1999-2000. 1 Estimates of "appropriate care" -defined here as care in line with evidence-based or consensusbased guidelines 2 -are limited in most countries, including Australia, to small groups of conditions, often in particular settings. 3, 4 Despite some evidence of great variations in care and poor compliance with guidelines (Box 1), no comprehensive study of the appropriateness of the health care received by Australians has been undertaken. Without such information, we will be unable to create sustainable systems that have "the capacity to measure, monitor and act on health care performance data". 8 Financial considerations alone would suggest that maximising the rate at which patients receive appropriate care is a national priority. 9 The aim of the CareTrack Australia study reported here was to determine the percentage of health care encounters at which a sample of Australians received appropriate care. 2 
Methods
Details of the CareTrack study methods have been published elsewhere. 2 The methods were based on the US study 1 but differed in three main ways. Rather than convening expert panels, we recruited individual clinical experts to develop our clinical indicators; we recruited participants from rural and remote areas, in addition to metropolitan areas; and we conducted onsite medical record review rather than reviewing copied records at a central location.
Selection of conditions
We selected 22 conditions that include several of the most common in Australia, according to estimates of the burden of disease 10 and studies of primary care activity. 11 Fourteen of the 22 are National Health Priority Areas, 12 and 15 were included in the US study.
1 Three conditions 2 -venous thromboembolism, surgical site infection, and antibiotic userepresent evidence-practice gaps. 13, 14 Although cancers account for 20% of disability-adjusted life-years, 10 they were not included because of low projected numbers in the sample. Instead, screening indicators for colorectal, lung, breast and prostate cancer were included within the condition "preventive care". Falls and pressure ulcers were not included because they were already being studied. the US study and other sources of indicators and guidelines.
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Development and ratification of indicators
2 At the start, we rejected indicators not likely to be documented, such as a recommendation for "gowning and gloving" for a sterile procedure. The 22 conditions were grouped into 11 specialty areas, and experts considered to be clinical leaders in their fields were identified and sent indicators for each relevant condition, together with a CareTrack information pack and a request for them to participate in the review process.
In total, 657 candidate indicators (range, 5-57 indicators per condition) were sent to 319 reviewers. Of these experts, 45 (14%) responded, providing comments, suggestions and appropriateness scores for each of the indicators they received. Response rates ranged from 3/3 for haematologists to 0/69 for general practitioners. One GP did respond, but had been chosen because of his expertise in one condition.
This process resulted in 522 indicators being ratified as representing appropriate care in line with that expected in 2009-2010. Compliance with these indicators was used to determine whether key aspects of appropriate care were adhered to in the study sample. All 522 indicators, with their source, number of reviewers, mean appropriateness score, level of evidence, and whether they were underuse or overuse indicators, are listed in Appendix 1 (online at mja.com.au). For example, an indicator measured for overuse was "patients with atrial fibrillation were NOT prescribed warfarin if there was evidence of active bleeding", and an indicator measured for underuse was "patients hospitalised with asthma were prescribed systemic steroids".
Recruitment of participants
Box 2 shows the stages of recruitment, and reasons for participant attrition. The sample was designed to be representative of the socioeconomic characteristics and location of the Australian population. 16 Residential landline telephone numbers in selected areas in N ew S out h Wal e s an d S out h Australia 17, 18 were randomly chosen from the online White Pages (http:// www.whitepages.com.au).
Trained staff conducted computerassisted telephone interviews to recruit participants and obtain information. At the first telephone interview, the aims of the CareTrack study were explained and participation sought. Respondents who agreed to participate were sent study information and consent forms. Those who consented to having their medical records accessed were asked at a second interview whether they had one or more of the 22 selected conditions during 2009-2010. If they did, they provided details of their health care providers (HCPs) and facilities. Participants were excluded if, during 2009-2010, they had not visited any HCPs, did not have one of the 22 conditions, or had attended a hospital for a day procedure only (with the exception of those who attended for endoscopy for dyspepsia).
Recruitment of health care providers
The 511 HCPs correctly identified by participants were sent an information pack and consent form to allow access to the participants' medical records. Of these HCPs, 225 (44%) provided consent.
Review of the medical records
We developed a web-based tool for onsite encrypted data collection. Registered nurses were employed as surveyors and underwent 3 days of training. Agreement between the trainer and surveyors was initially assessed using an artificially created medical record encompassing all conditions ( = 0.70; 95% CI, 0.68-0.72). We developed a surveyor manual that included instructions, condition-specific definitions, inclusion and exclusion criteria, and guidance for assessing eligibility of each encounter for relevant indicators.
Surveyors assessed all components of electronic and paper records for 2009-2010, including laboratory results, referral letters and entries by practice nurses and allied health professionals. Surveyors answered each indicator question as "yes" (evidence that care provided during an eligible encounter was consistent with the indicator), "no" (no evidence that care provided during an eligible encounter was consistent with the indicator), or "not applicable" (the encounter was not eligible for the indicator in question).
2 Indicators deemed ineligible at any particular encounter were not scored or included in calculating compliance. Our web-based tool filtered out encounters in which an indicator was ineligible, based on algorithms taking into account the type of HCP or facility and the participant's condition and sex (eg, male participants were not eligible for a mammogram). Surveyors deemed a further set of encounters as being ineligible for an indicator using exclusion criteria such as allergies, known contraindications and specific comorbidities or treatments (eg, a patient for whom anticoagulation was indicated but who was at risk of bleeding; a patient in whom -blockers were indicated but who had a history of asthma; a patient with asthma who did not have an exacerbation during the study period).
Although each indicator had associated inclusion and exclusion criteria, it was impossible to list every conceivable criterion, and surveyors were encouraged to use their clinical judgement to make decisions about the eligibility of each indicator at any particular encounter. Weekly meetings were held to progressively harmonise surveyors' views. A convenience sample of records was also reviewed by the trainer of the surveying team at certain hospitals and health care facilities. Agreement between the trainer and the surveyors varied between elements of the record review -presence or absence of a particular condition ( = 0.87; 95% CI, 0.82-0.91), eligibility of indicators ( = 0.58; 95% CI, 0.53-0.63) and scoring of indicators ( = 0.50; 95% CI, 0.45-0.55). Of 2416 duplicate reviews, 243 (10%) were discrepant. Four situations within three conditions gave rise to 98 (40%) of these discrepancies: disagreements about classification of the type of surgery (clean or contaminated), the timing of prophylactic antibiotics, or whether a patient was presenting with unstable or stable angina; and because some surveyors assumed a risk assessment had been carried out for patients appropriately receiving venous thromboembolism (VTE) prophylaxis, when there was no record of this.
Statistical analysis
Compliance was measured as the percentage of eligible encounters at which the indicator question was answered "yes". Condition-level and overall results were obtained by combining indicator-level data. Modified Clopper-Pearson (exact) 95% confidence intervals were calculated using PROC SURVEYFREQ in SAS version 9.3 for Windows (SAS Institute, Cary, NC, USA), with Taylor series linearisation 19 to estimate the variance; this takes into account the complex sampling design. Detailed indicator-level and condition-level results are beyond the scope of this article and will be reported separately.
Eligibility criteria and the need for respondents to have at least one of the study conditions meant that weighting the final sample to the general population was inappropriate. Several weighting procedures were nevertheless considered, and two options with five sub-versions were carried out (including one similar to that used in the US study 1 ). As overall compliances were stable with these five different weighting options (see Appendix 2, online at mja.com.au), unweighted results are presented here.
Ethics approval and statutory immunity
Ethics approval was obtained from all relevant bodies and sites.
2 The identities of all patients, HCPs and facilities were protected by gaining statutory immunity for CareTrack as a quality assurance activity from the federal Minister for Health under Part VC of the Health Insurance Act 1973 (Cwlth).
Results
Demographics of participants and health care providers
There were 1154 participants in the final sample (Box 2), with a mean age of 63 years (range, 19-96 years); 669 (58%) were female. The average number of conditions per participant was 2.9 (range, 1-11). At interview, participants nominated an average of two HCPs (range, 1-7). The mean number of HCP records accessed by surveyors was 1.3 per participant (range, 1-4). Surveyors assessed a total of 270 052 encounters; of these, 234 479 were deemed ineligible through software filtering (84 937) or surveyor review (149 542), leaving 35 573 eligible encounters between participants and HCPs.
Participants at the first interview and in the final sample closely matched the distribution of the Australian population by region (Box 3). The mean Index of Relative Socioeconomic Disadvantage of our sample was 993 (similar to the nationwide mean of 1000), with a range of 764-1122, spanning all five quintiles. Differences between our sample and the putative reference population are discussed in Appendix 2.
Almost half (107) of the 225 consenting health care facilities were general practices (23 378 eligible encounters), followed by 51 specialist practices (1303 eligible encounters) and 33 hospitals (6120 eligible encounters). The remainder were chiropractic (19) , physiotherapy (10), psychology (4) and mental health practices (1) (4772 eligible encounters). Over 80% of general practices used electronic health records, compared with 43% for specialists, 8% for other HCPs, and 3% for hospitals.
Analysis of care delivered
Box 4 shows the numbers of indicators, participants, and eligible encounters for each condition, and the percentage of encounters at which appropriate care was received. Box 5 provides a graphical representation.
Overall, Australians in our sample received appropriate care at 57% (95% CI, 54%-60%) of 35 573 eligible encounters. With weighting, the percentage of appropriate care ranged from 54% to 57% (see Appendix 2). For 39 HCPs with more than 300 eligible encounters each, compliance ranged from 32% to 86%.
Compliance was poor across conditions for the use of recommended risk assessment tools and appropriate responses to severe or deteriorating conditions. Four indicators measured the use of tools for condition-specific risks (Australian type 2 diabetes risk assessment tool [AUSDRISK], 20 
ABCD
2 for cerebrovascular accident, 21 and CURB-65 22 or Pneumonia Severity Index 23 for community-acquired pneumonia). Overall compliance with use of these tools was 1% (range, 0-21%). As an example of a poor response to patients with severe or deteriorating conditions, 5% of 40 encounters involving participants with a blood pressure level у 180/ 110 mmHg and 40% of 124 encounters with participants with a blood pressure level у 140/90 mmHg were handled appropriately. 
Discussion
Australian patients in our sample received appropriate care at an average of 57% of eligible encounters during 2009 and 2010. This figure is strongl y c onc ord an t wit h t he weighted average of 55% of participants receiving "recommended care" reported from the US. 1 Although there were pockets of excellence, with some individual HCPs complying with over 80% of indicators, and high overall compliance for some conditions (eg, 90% for coronary artery disease), much of the care provided in Australia appears to fall short of the ideal. Compliance was as low as 32% for some practices, and compliance was very low for some indicators (eg, only 1% for use of four risk assessment tools and only 5% for an appropriate response to severe hypertension).
It may be argued that the routine use of explicit risk assessment tools is unnecessary for experienced practitioners. For example, some surveyors assumed that patients who received appropriate VTE prophylaxis had been risk assessed, despite there being no documented evidence of this in the medical record. In debating whether this was acceptable, other surveyors pointed out that some hospitals included a VTE risk assessment tool in their admission documentation and that their patients were risk assessed at admission. These surveyors observed a higher rate of compliance in these hospitals, particularly with administration of prophylaxis for medical patients, supporting the routine use of risk assessment tools in appropriate contexts, in line with recommendations in national guidelines. This would seem to be an area that could be targeted for system-wide improvement.
What are the implications of our findings for Australian health care? Some advantages of using process measures as indicators were cited by the US study: they represent the activities that clinicians control most directly … they do not generally require risk adjustment [and] they are consistent with the structure of national guidelines.
1
Process measures can therefore be good targets for improvement. The issue of process versus outcome measurement has recently received attention. 24, 25 Publications from the US study 1, 26 provide some examples of strong links between compliance with process indicators and outcomes. Some processes examined in our study (data not shown), such as monitoring glycated haemoglobin levels in patients with diabetes (75% compliance here v 24% in the US study), and those for handling communityacquired pneumonia (52% compliance here v 39% in the US study) have outcome implications at both individual and societal level (for cardiovascular morbidity and antibiotic use, respectively). An example of a close link between process and outcome from CareTrack is the poor compliance (16%) with recommended timing of prophylactic antibiotics for reducing surgical site infection, which negates much of the positive impact of the antibiotics given. This finding is consistent with that from another Australian study. 27 The cost of surgical site infection in Australia has been estimated at $268 million per year. 14 Our study has some limitations. Study conditions were limited to those with sufficient prevalence to obtain meaningful results within the scope of the project. Nevertheless, these conditions account for nearly half the burden of disease in Australia.
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Although over 90% of indicators were reviewed during development by at least three experts (with most scored as appropriate [17%] or very appropriate [74%]), we received fewer than three expert responses for three conditions (obesity, communityacquired pneumonia and antibiotic use), despite sending these indicators to 69 reviewers. These were reviewed by clinicians in the research team (Appendix 1).
The use of a population-based rather than a convenience design is both a strength and a weakness. The strength lies in the ability to provide * Encounters where surveyor answered indicator question as "yes" (evidence that care provided during an eligible encounter was consistent with the indicator) or "no" (no evidence that care provided during an eligible encounter was consistent with the indicator). † National Health Priority Area for Australia. ‡ Conditions included in the United States study. 1 § Four conditions included screening indicators at population level. The number of participants eligible for screening were: hypertension, 362; diabetes, 587; osteoporosis, 608; hyperlipidaemia, 491. ¶ Preventive care includes indicators for alcohol consumption and screening for cancers (breast, cervical, prostate and colon). ◆ robust estimates across a range of HCPs, but the weakness is that there was a high attrition rate. The US study also had a high attrition rate, underlining the challenges of recruitment and consent. Further, our survey used a landline-based telephone survey, thus excluding people with only mobile phones. Nevertheless, telephone surveys together with poststratification weighting (which we found did not change the results markedly) are still used both in Australia 28 and internationally. The possible omission of people with poor English skills may limit the generalisability of our results, but does not negate them for the general population.
Recruitment of HCPs introduced further sources of potential bias. It was limited by participant recall of the names and locations of their providers, and over half of the HCPs and practices contacted declined access to consenting patients' records.
With respect to record review, if there was no documented evidence of an action, eligibility and/or compliance could not be assumed. Any overe stim at io n of no n-c om pli anc e associated with lack of documentation has been reported to be no more than 10%.
1 Although  scores between the trainer and surveyors were good for the artificially created medical record, they were moderate for implicit review of records in the field, due to the inconsistent structure of medical records and problems such as poor handwriting. This is consistent with other studies, 29 underscoring the desirability of standardised electronic tools for facilitating and documenting care. The trainer's results were not included in the final sample; had they been, compliance would have been lower than reported here. The types of discrepancies seen between the trainer and surveyors' reviews are typical problem situations with implicit medical record review. 29 Overall, our study identified highly variable care and poor compliance with some important indicators. The consistent delivery of appropriate care needs improvement, and the gaps in care that we identified should be addressed. The Cochrane Collaboration has provided some evidence that the use of standardised practice and feedback is associated with improvements. 30, 31 This was supported by the experience of the CareTrack surveyors and has been identified by others. 32, 33 Over 90% of Australians see a GP each year, 34 and most of these practitioners use electronic information systems. Better design and more effective use of such systems by providers and patients represents a major opportunity for improving the appropriateness of health care. 35 There is an urgent need to agree at a national level what constitutes basic care for important conditions, to embed this information in clinical standards, and for groups of experts to ensure that these standards are kept up to date. This must be a dynamic process that takes into account the relative importance of different indicators in different contexts and at different stages of life. Redundant guidelines must be retired and, with better structured medical records, continuous improvement based on ongoing monitoring of the appropriateness of care should become an intrinsic part of health care. Elsewhere in this issue of the Journal, we discuss the barriers to achieving this and offer recommendations for how they may be overcome. 
